HLA-C and melanoma: In parallel, exome sequencing and high-throughput MHC tetramer screening showed higher expansion of pre-existing T cells specific for tumor neoantigens in a human melanoma patient after treatment with checkpoint blockade immunotherapy (Van Rooij et al., 2013).